GlassScriptPhysician profile
Vidya Seshadri
NPI 1184843369
$24,333.67
in general payments reported to CMS, 2019-2025
100 companies · $7,868 in 2025
The $7,868 reported for 2025 was more than what 86% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,006 · 2020: $424 · 2021: $565 · 2022: $4,394 · 2023: $5,555 · 2024: $4,522 · 2025: $7,868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Travel and Lodging: $2,652 · Education: $595 · Gift: $39.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,657.92 |
| Travel and Lodging | $2,652.21 |
| Education | $594.95 |
| Gift | $39.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| US Oncology Corporate, INC. | $4,029.66 | 2022-2024 | |
| Onmark, INC. | $2,807.81 | 2025 | |
| Pfizer INC. | $1,156.00 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,139.17 | 2019-2025 | Piqray, Kisqali |
| Astrazeneca Pharmaceuticals LP | $1,054.45 | 2019-2025 | Tagrisso, Lynparza, Enhertu |
| Astellas Pharma US INC | $843.61 | 2019-2025 | Xtandi, Xospata, Vyloy |
| Genentech USA, INC. | $766.17 | 2019-2025 | Polivy, Venclexta, Tecentriq |
| Janssen Biotech, INC. | $631.61 | 2019-2025 | Darzalex, Erleada, Rybrevant |
| E.R. Squibb & Sons, L.L.C. | $619.43 | 2019-2025 | Opdivo, Opdualag, Reblozyl |
| Daiichi Sankyo INC. | $611.58 | 2022-2025 | Enhertu, Injectafer, Datroway |
| Merck Sharp & Dohme LLC | $545.97 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Genzyme Corporation | $523.90 | 2021-2025 | |
| Incyte Corporation | $510.41 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Celgene Corporation | $508.13 | 2020-2025 | Reblozyl, Pomalyst, Opdualag |
| Alexion Pharmaceuticals, INC. | $476.24 | 2019-2025 | Ultomiris, Soliris |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $449.97 | 2019-2025 | Venclexta |
| Takeda Pharmaceuticals U.S.A., INC. | $418.27 | 2022-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Amgen INC. | $403.15 | 2019-2023 | Lumakras, Nplate, Xgeva |
| Glaxosmithkline, LLC. | $396.48 | 2019-2025 | Zejula, Jemperli, Ojjaara |
| Aveo Pharmaceuticals, INC. | $306.09 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $277.71 | 2019-2025 | Libtayo, Lynozyfic |
| Seagen INC. | $277.70 | 2019-2023 | Tukysa, Adcetris, Padcev |
| Gilead Sciences, INC. | $256.31 | 2019-2025 | Trodelvy |
| Genmab U.S., INC. | $251.25 | 2023-2025 | Tivdak, Epkinly |
| Emd Serono, INC. | $226.78 | 2020-2025 | Bavencio, Tepmetko |
| Lilly USA, LLC | $209.83 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Rigel Pharmaceuticals, INC. | $209.33 | 2022-2024 | Tavalisse, Rezlidhia |
| Eisai INC. | $205.02 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $192.68 | 2019-2025 | Onivyde |
| Jazz Pharmaceuticals INC. | $180.42 | 2019-2025 | |
| Kyowa Kirin, INC. | $180.02 | 2020-2024 | Poteligeo |
| Bayer Healthcare Pharmaceuticals INC. | $174.04 | 2019-2025 | |
| Novo Nordisk INC | $153.93 | 2022 | |
| Geron Corporation | $148.23 | 2024-2025 | Rytelo |
| Exelixis INC. | $122.89 | 2019-2025 | Cabometyx |
| Stemline Therapeutics INC. | $118.40 | 2023-2025 | Orserdu, Elzonris |
| Pharmacosmos Therapeutics INC. | $111.59 | 2023-2025 | Monoferric, Cosela |
| Pharmacyclics LLC, An Abbvie Company | $108.77 | 2019-2022 | |
| Karyopharm Therapeutics INC. | $105.67 | 2020-2024 | Xpovio |
| Tersera Therapeutics LLC | $105.47 | 2022-2025 | Zoladex, Xermelo, Quzyttir |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.01 | 2021-2025 | |
| Blueprint Medicines Corporation | $96.26 | 2023-2024 | Ayvakit |
| Agios Pharmaceuticals, INC. | $96.06 | 2020-2025 | Pyrukynd |
| Kite Pharma, INC. | $94.97 | 2020-2025 | Yescarta |
| Tesaro, INC. | $92.82 | 2019 | |
| Puma Biotechnology, INC. | $90.69 | 2023-2025 | Nerlynx |
| Sobi, INC | $87.46 | 2022-2024 | |
| Pharmaessentia USA Corporation | $86.09 | 2022-2025 | Besremi |
| Beigene USA, INC. | $81.31 | 2020-2024 | Brukinsa, Tevimbra |
| Fennec Pharmaceuticals, INC. | $78.63 | 2025 | Fyarro |
| Array Biopharma INC | $73.45 | 2021-2025 | Mektovi, Braftovi, Lorbrena |
| Mirati Therapeutics, INC. | $73.36 | 2023-2024 | Krazati |
| Octapharma USA, INC. | $66.88 | 2024-2025 | Octagam Immune Globulin (Human) |
| Beone Medicines USA, INC. | $63.42 | 2025 | Brukinsa |
| Sumitomo Pharma America, INC. | $53.99 | 2023-2025 | Orgovyx |
| Syndax Pharmaceuticals, INC. | $52.63 | 2025 | Revuforj |
| Tempus Ai, INC | $51.51 | 2024 | |
| Springworks Therapeutics, INC. | $51.18 | 2024-2025 | Ogsiveo, Gomekli |
| Immunocore Limited | $50.90 | 2025 | Kimmtrak |
| Sun Pharmaceutical Industries INC. | $49.95 | 2023-2025 | Yonsa, Odomzo |
| Iovance Biotherapeutics, INC. | $48.98 | 2025 | Amtagvi |
| Sanofi-Aventis U.S. LLC | $45.08 | 2023 | |
| Adaptive Biotechnologies Corporation | $43.85 | 2022-2025 | Clonoseq |
| Taiho Oncology, INC. | $43.60 | 2023-2025 | |
| Clovis Oncology, INC. | $38.10 | 2019-2022 | |
| Coherus Oncology, INC. | $35.94 | 2020-2023 | |
| Morphosys, US INC. | $35.57 | 2022-2023 | Monjuvi |
| Adc Therapeutics America, INC. | $35.00 | 2022-2023 | |
| Servier Pharmaceuticals LLC | $34.71 | 2024-2025 | |
| Recordati_rare_diseases_inc. | $32.04 | 2023-2025 | Sylvant |
| Hema Biologics, LLC | $30.11 | 2021 | |
| Pharmaand Gmbh | $29.37 | 2025 | Rubraca |
| Tolmar, INC. | $29.37 | 2025 | Rubraca |
| Dova Pharmaceuticals | $28.82 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $27.48 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $26.21 | 2023 | Firdapse |
| Apellis Pharmaceuticals, INC. | $25.32 | 2024 | Empaveli |
| Foundation Medicine, INC. | $25.24 | 2023 | Foundationone Liquid Cdx |
| Progenics Pharmaceuticals, INC. | $25.15 | 2024 | |
| Monteris Medical Corporation | $25.12 | 2025 | Neuroblate |
| Verity Pharmaceuticals INC. | $24.84 | 2023 | Trelstar |
| Alnylam Pharmaceuticals INC. | $23.27 | 2024 | Onpattro |
| Nestle Healthcare Nutrition INC. | $21.00 | 2022 | |
| Legend Biotech USA INC. | $20.99 | 2025 | Carvykti |
| Tg Therapeutics, INC. | $20.87 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $20.71 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $20.27 | 2024 | Sancuso |
| Caris Mpi, INC. | $18.60 | 2025 | Mi Cancer Seek |
| Mylan Institutional INC. | $18.45 | 2022 | |
| Amneal Pharmaceuticals LLC | $18.19 | 2025 | Pemrydi Rtu |
| G1 Therapeutics, INC. | $17.97 | 2023 | Cosela |
| Verastem, INC. | $17.30 | 2019 | |
| Global Blood Therapeutics, INC. | $17.19 | 2022 | |
| Deciphera Pharmaceuticals INC. | $17.02 | 2021 | |
| Myovant Sciences INC. | $16.24 | 2021 | |
| Cti Biopharma Corp. | $15.78 | 2023 | Vonjo |
| Telix Pharmaceuticals | $15.28 | 2024 | Illuccix |
| Novocure INC. | $14.76 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $13.25 | 2019 | |
| Mckesson Specialty Care Distribution, LLC | $11.92 | 2019 |
Drugs and devices associated with these payments
Enhertu $572Xtandi $531Tagrisso $490Venclexta $421Lynparza $403Keytruda $361Kisqali $318Reblozyl $303Ultomiris $276Opdivo $265Talzenna $258Inlyta $242Libtayo $223Jakafi $219Epkinly $214Orgovyx $209Padcev $208Ibrance $200Darzalex $198Fotivda $193Polivy $176Monjuvi $165Lenvima $162Fruzaqla $159Rytelo $148Tavalisse $140Rezlidhia $140Zepzelca $140Onivyde $140Opdualag $138Sarclisa $132Zejula $131Jemperli $131Imbruvica $129Alunbrig $128Elrexfio $128Adcetris $126Trodelvy $125Ayvakit $123Tivdak $123Fabhalta $121Erleada $121Nubeqa $117Tecentriq $117Rybrevant $117Tecvayli $115Lutathera $110Brukinsa $110Ojjaara $109Poteligeo $105Xospata $103Tukysa $103Cablivi $103Orserdu $102Enjaymo $101Jaypirca $99.01Verzenio $99.01Phesgo $98.59Krazati $91.98Bosulif $91.87Cabometyx $91.70Stivarga $90.50Injectafer $89.79Bavencio $87.87Piqray $86.52Talvey $84.53Lorbrena $83.83Wayrilz $78.77Itovebi $78.68Fyarro $78.63Monoferric $78.37Scemblix $77.77Vonjo $73.50Lunsumio $73.46Vitrakvi $73.14Xpovio $72.69Pemazyre $71.65Xyntha $71.12Benefix $71.12Xalkori $69.59Ninlaro $68.21Octagam Immune Globulin (Human) $66.88Hympavzi $66.56Welireg $66.18Besremi $62.17Columvi $60.10Xofigo $59.10Rubraca $58.74Cosela $51.19Kimmtrak $50.90Mektovi $50.69Braftovi $50.69Vyloy $50.36Pyrukynd $50.02Odomzo $49.95Amtagvi $48.98Comirnaty $47.29Pomalyst $47.04Pluvicto $47.02Zoladex $46.70
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vidya Seshadri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.